RecallHawk
Class II Recall

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500

Granules Pharmaceuticals Inc.

Summary

The FDA issued a Class II for Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: by Granules Pharmaceuticals Inc.. Reason: Presence of Foreign Tablets/Capsules.

Details

Source

Drug Recall

External ID

D-0305-2026

Action Date

2026-02-11

Status

Ongoing

Category

drug

Product Description

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.

Lot/Code Info: Batch # 6160008A, Exp Date: 12/31/2026

Quantity Affected: 71424 bottles.

Reason for Recall

Presence of Foreign Tablets/Capsules

Distribution

US Nationwide.

Type: Voluntary: Firm initiated

Recall Initiated: 2026-01-26

Company

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 40 drug recalls issued in the same week, part of 267 drug-related FDA actions this month.

Granules Pharmaceuticals Inc. has 10 FDA actions in our database, including 10 recalls.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Granules Pharmaceuticals Inc.) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Granules Pharmaceuticals Inc. have FDA actions?

Granules Pharmaceuticals Inc. has 10 FDA actions in our database, including 10 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "D-0305-2026" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions